Autopsy report · NCT04614467
A Placebo-Controlled Trial of CLBS16 in Subjects With Coronary Microvascular Dysfunction
Cause of deathFunding or business
“Sponsor decision”
Life of this trial
- Ran for about 1 year 11 months before it stopped.
- 34 participants enrolled.
- Results were posted on the registry 3 years 7 months after it ended.
Vital statistics
- Status
- Terminated
- Phase
- Phase 2
- Sponsor
- Lisata Therapeutics, Inc.
- Sponsor type
- Industry
- Conditions
- Coronary Microvascular Dysfunction; Coronary Microvascular Disease; Microvascular Coronary Artery Disease
- Interventions
- CLBS16; Placebo
- Participants
- 34
- Sites
- 7
- Countries
- United States
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.